John E. Kao - Mar 29, 2023 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Stock symbol
ALHC
Transactions as of
Mar 29, 2023
Transactions value $
-$210,946
Form type
4
Date filed
3/31/2023, 05:00 PM
Previous filing
Mar 15, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale -$211K -34.5K -1.45% $6.11 2.35M Mar 29, 2023 Direct F1, F2
holding ALHC Common Stock 2.72M Mar 29, 2023 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.